My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Avita Medical, Inc. - Common Stock (NQ:RCEL)

5.200 -0.130 (-2.44%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Avita Medical, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
AVITA Medical Submits FDA PMA Supplement to Further Expand Indication to Soft Tissue Repair
From AVITA Medical
Via GlobeNewswire
AVITA Medical® to Present at the Piper Sandler 34th Annual Healthcare Conference
From AVITA Medical
Via GlobeNewswire
AVITA Medical® to Host Investor Webinar Briefing
From AVITA Medical
Via GlobeNewswire
AVITA Medical: Q4 Earnings Insights
  AVITA Medical (NASDAQ:RCEL) reported its Q4 earnings results on Thursday, August 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For August 11, 2022
Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low. 
Via Benzinga
AVITA Medical: Q2 Earnings Insights
AVITA Medical (NASDAQ:RCEL) reported its Q2 earnings results on Monday, February 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
AVITA Medical Reports Third Quarter 2022 Financial Results
From AVITA Medical
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers NexImmune (NASDAQ:NEXI) shares rose 38.8% to $0.7 during Thursday's pre-market session. The market value of their outstanding shares is at $16.9 million. 
Via Benzinga
AVITA Medical Announces Achievement of Co-Primary Endpoints in Updated Analysis of Pivotal Trial of RECELL® System for Soft Tissue Repair
From AVITA Medical
Via GlobeNewswire
Earnings Scheduled For February 28, 2022
Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (... 
Via Benzinga
Earnings Scheduled For November 10, 2022
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report earnings for its third quarter. 
Via Benzinga
AVITA Medical Announces FDA Breakthrough Device Designations for the RECELL® System
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Announce Third Quarter 2022 Financial Results
From AVITA Medical
Via GlobeNewswire
AVITA Medical Appoints Industry Leader James Corbett as Chief Executive Officer
From AVITA Medical
Via GlobeNewswire
Investor Webinar Briefing (RCEL, AVH)
Valencia, California and Melbourne, Australia--(Newsfile Corp. - September 19, 2022) - AVITA Medical, Inc. (NASDAQ: RCEL) (ASX: AVH), a regenerative... 
Via Newsfile
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
 
Via Benzinga
AVITA Shares Climb Following Positive Results From RECELL System Study In Stable Vitiligo Lesions
AVITA Medical (NASDAQ: RCEL) reveals positive top-line results from a pivotal trial evaluating the safety and effectiveness of the RECELL System for repigmentation of stable vitiligo lesions. 
Via Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
 
Via Benzinga
AVITA Medical Shares Climb On Topline Results From Soft Tissue Reconstruction Study, Sees PMA Submission By Year-end
AVITA Medical (NASDAQ: RCEL) announced topline results from its pivotal trial evaluating the safety and effectiveness of the RECELL System combined with meshed autograft for reduction of donor skin... 
Via Benzinga
AVITA Medical: Q3 Earnings Insights
AVITA Medical (NASDAQ:RCEL) reported its Q3 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings AVITA Medical beat estimated... 
Via Benzinga
Earnings Scheduled For May 12, 2022
Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter. 
Via Benzinga
AVITA Medical Modifies BARDA Contract For RECELL System In Soft Tissue Reconstruction
Biomedical Advanced Research and Development Authority (BARDA) has  
Via Benzinga
AVITA Medical Inks Supply Pact With Premier For RECELL System
AVITA Medical Inc (NASDAQ: RCEL) has been awarded a group purchasing agreement with Premier Inc (NASDAQ: PINC) The new agreement allows Premier members,... 
Via Benzinga
The Daily Biotech Pulse: NuCana Shelves Biliary Tract Cancer Study, Tricida Data Readout Pushed Back Due to Ukrainian Crisis, Synlogic Names New CFO
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus NuCana Discontinues Biliary Tract Cancer Study Following Futility Analysis... 
Via Benzinga
44 Stocks Moving In Tuesday's Mid-Day Session
Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) climbed 193% to $0.9962 after jumping 36% on Monday. GBS Inc. (NASDAQ: GBS) rose 73.3% to $0.7971 after declining around 9% on... 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's session, 454 stocks hit new 52-week lows. Intriguing Points From Today's 52-Week Lows: Taiwan Semiconductor (NYSE:TSM) was the largest company by... 
Via Benzinga
80 Biggest Movers From Yesterday
Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) jumped 78.5% to close at $0.6066 on Tuesday after jumping 36% on Monday. CTI BioPharma Corp. (NASDAQ: CTIC) surged 63... 
Via Benzinga
Futures Flat As Traders Brace For Op-Ex Volatility, More Ukraine Headlines
In the latest geopolitical developments Russian Foreign Minister Sergei Lavrov agreed to meet US Secretary of State Antony Blinken for talks in Europe next week; German Chancellor Olaf Scholz will host... 
Via Talk Markets
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Creative Medical Tech (NASDAQ:CELZ 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.